Are there clinical trials combining immunotherapy with other treatments for Lung Cancer

Lung CancerMay 15, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Clinical Trials Combining Immunotherapy with Other Treatments for Lung Cancer

Yes, there are several clinical trial approaches combining immunotherapy with other treatments for lung cancer. Let me explain how doctors are using these combinations and what the evidence shows.

How Doctors Think About Combination Immunotherapy

Oncologists have learned that immunotherapy (drugs that help your immune system fight cancer) often works better when combined with other treatments. The reasoning is that different treatments attack cancer in different ways—chemotherapy kills cancer cells directly, radiation damages them locally, and immunotherapy "wakes up" your immune system to recognize and destroy cancer cells.

General Treatment Combinations Being Studied

According to the NCCN Guidelines for Patients: Non-Small Cell Lung Cancer, several combination approaches are being used:

1. Immunotherapy After Chemoradiation

  • For early and locally advanced NSCLC, patients may receive chemotherapy and radiation therapy together, followed by immunotherapy drugs like durvalumab or osimertinib to improve the chance of cure
  • This sequential approach allows the initial treatments to reduce tumor burden, then immunotherapy helps prevent recurrence

2. Immunotherapy with Chemotherapy

  • Combining immunotherapy drugs with platinum-based chemotherapy regimens (the standard chemotherapy approach for lung cancer)
  • This concurrent approach may be used for advanced disease

3. Immunotherapy with Targeted Therapy

  • For patients with specific genetic mutations (like EGFR mutations), combining immunotherapy with targeted drugs

Important Context About Clinical Trials

If you're interested in clinical trials specifically, here's what you should know:

  • Trial availability varies by your specific cancer stage, type (adenocarcinoma, squamous cell, etc.), and genetic markers
  • Your oncologist can help identify trials you may be eligible for based on your complete medical picture
  • Trials test new combinations before they become standard treatment

Questions to Ask Your Oncology Team

  1. Are there clinical trials available for my specific type and stage of lung cancer?
  2. Would a combination approach (chemotherapy + radiation + immunotherapy) be appropriate for my situation?
  3. What are the potential benefits and side effects of combining these treatments?
  4. How would my response be monitored if I participated in a trial?
  5. Are there any trials specifically testing the combination approach you're recommending for me?

Where to Find More Information

  • ClinicalTrials.gov - Search for lung cancer trials in your area
  • NCCN.org - Patient guidelines with current treatment information
  • Your cancer center - Many major centers have dedicated trial coordinators

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: